CreatorsPublishersAdvertisers
View more in
General Motors

For Cell and Gene Therapy Products, Early Characterization is Critical

Genetic Engineering News
 2021-07-21

Cover picture for the articleYears of research and innovation within the cell and gene therapy space are rapidly showing signs of success, as an ever-increasing list of therapeutics have either already been approved for clinical use or are set to burst on the scene. Biomanufacturers have developed cutting-edge processes to create these life-saving compounds. Still, safety is always a paramount concern, and companies are constantly looking for new ways to improve their product and pipelines. Subvisible particle contamination is the leading cause of drug product recalls and a critical quality attribute, and improved modalities to easily detect and identify these particles are crucial.

www.genengnews.com

Comments / 0

Comments / 0